'No harm, potential benefits': ICMR continues recommendation on use of hydroxychloroquine for preventive treatment

Responding to a query on the efficacy of hydroxychloroquine during a media briefing on COVID-19, ICMR chief Balram Bhargava said biological plausibility of HCQ was supporting that it might be an antiviral drug.